Subsidiary18 May 2026, 07:41 pm
Kopran: Chandresh Gandhi Appointed Director; Rights Issue in Subsidiary
AI Summary
Kopran Ltd announced the appointment of Mr. Chandresh Gandhi as an Additional Director (Non-Executive, Independent Category) of its subsidiary, Kopran Research Laboratories Limited (KRLL), for a five-year term starting May 18, 2026. KRLL will also issue rights shares at a premium of ₹90 each, utilizing the raised funds (₹18.75 Cr) for working capital.
Key Highlights
- Mr. Chandresh Gandhi appointed as Additional Director (Independent) of Kopran Research Laboratories Ltd.
- Gandhi's term is for five years, from May 18, 2026, to May 17, 2031, subject to shareholder approval.
- KRLL will issue rights shares to raise ₹18.75 Cr for working capital.
- The rights issue is structured as 1 share for every 12 held, with a face value of ₹10 and a premium of ₹90 per share.
Price Impact
More from KOPRAN